Malawi needs to develop plan addressing country's AIDS orphans

The number of AIDS orphans in Malawi is a "potential looming catastrophe," and the country needs to develop a comprehensive action plan to address the situation, U.N. Special Envoy for HIV/AIDS in Africa Stephen Lewis said recently, the Chronicle/AllAfrica.com reports (Gondwe, Chronicle/AllAfrica.com, 11/6).

According to officials, there are about 83,000 children living with HIV/AIDS in Malawi, and 900,000 children have lost one or both parents to AIDS-related illnesses.

Six percent of the 50,000 HIV-positive people living in Malawi who receive antiretroviral drugs are children (Kaiser Daily HIV/AIDS Report, 11/6).

Malawi recorded 100,000 new HIV cases in 2005, and 26,000 infants were born HIV-positive during the same time period, according to Mary Shawa, Malawi's principal secretary for HIV/AIDS and nutrition.

"Because of our situation, most of the orphans do not go to school," Shawa said, adding, "We are bringing up the next generation that is HIV-positive, highly malnourished and will be illiterate. ... [W]e are sitting on a time bomb. Soon it will erupt."

To alleviate the problem, Malawi needs to implement a social welfare system that would provide money to "child-headed families, other vulnerable families and to the community," Lewis said, adding that the country needs more health facilities that offer prenatal clinical services for HIV-positive pregnant women.

Malawi also needs to provide increased access to mother-to-child HIV prevention methods, Lewis said (Chronicle/AllAfrica.com, 11/6).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines